Literature DB >> 18783017

Prevalence and characterization of verotoxin-producing Escherichia coli (VTEC) in cattle from an Ontario abattoir.

Musafiri Karama1, Roger P Johnson, Robert Holtslander, Scott A McEwen, Carlton L Gyles.   

Abstract

This study determined the prevalence of verotoxin (VT)-producing Escherichia coli (VTEC) in Ontario beef cattle at slaughter and characterized the isolates by serotype, virulence factors, virulence markers, and antimicrobial resistance. Cultures of rectal feces from 500 animals were screened for VT by an enzyme-linked immunosorbent assay (ELISA) and by polymerase chain reaction (PCR) for genes vt1, vt2, and eae. The VT-ELISA-positive samples were tested by a VT-immunoblot to isolate VTEC colonies. The prevalence rates of VTEC by VT-ELISA and PCR were 10.2% [95% confidence interval (CI), 7.8% to 13.2%] and 6.2% (95% CI, 4.4% to 8.7%), respectively. Colonies of VTEC were isolated from 27 (53%) of the 51 VT-ELISA-positive samples and belonged to 24 serotypes, which did not include O157:H7. Twelve of the serotypes have been implicated in disease in humans. Virulence profiling of the isolates by PCR revealed that 2 (8%) were eae-positive, 5 (21%) had vt1 only, and 19 (79%) had vt2, of which 3 had vt2 only, 7 had vt1 + vt2, 4 had vt2 + vt2c, 2 had vt2 + vt2c + vt2d, 2 had vt1 + vt2 + vt2c, and 1 had vt1 + vt2 + vt2c + vt2d. The distribution of selected plasmid-encoded putative virulence genes was as follows: ehxA, 63%; espP, 46%; saa, 67%; and subA, 54%. Nine of the 24 isolates were resistant to 1 or more antimicrobials. Major conclusions are that the VTEC prevalence of 10.2% was among the lower rates reported for beef cattle, a high proportion of the isolates had vt2 genes, the subA gene was reported for the 1st time in Canadian VTEC, and the absence of O157 VTEC likely reflects the use of a technique that detected all VTEC.

Entities:  

Mesh:

Year:  2008        PMID: 18783017      PMCID: PMC2442671     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  38 in total

1.  Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.

Authors:  Naoko Morinaga; Kinnosuke Yahiro; Gen Matsuura; Masaharu Watanabe; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

2.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors.

Authors:  Y Bertin; K Boukhors; N Pradel; V Livrelli; C Martin
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Prevalence and characteristics of shiga toxin-producing Escherichia coli in beef cattle slaughtered on Prince Edward Island.

Authors:  R D Schurman; H Hariharan; S B Heaney; K Rahn
Journal:  J Food Prot       Date:  2000-11       Impact factor: 2.077

6.  Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France.

Authors:  N Pradel; V Livrelli; C De Champs; J B Palcoux; A Reynaud; F Scheutz; J Sirot; B Joly; C Forestier
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa.

Authors:  Adrienne W Paton; James C Paton
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

8.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

9.  Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR.

Authors:  Gehua Wang; Clifford G Clark; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans.

Authors:  Carl M Schroeder; Jianghong Meng; Shaohua Zhao; Chitrita DebRoy; Jocelyn Torcolini; Cuiwei Zhao; Patrick F McDermott; David D Wagner; Robert D Walker; David G White
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  15 in total

1.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

2.  Prevalence of the operon encoding subtilase cytotoxin in non-O157 Shiga toxin-producing Escherichia coli isolated from humans in the United States.

Authors:  Jennifer J Wolfson; Dakshina M Jandhyala; Lynn A Gorczyca; Zulekha Qadeer; Shannon D Manning; James Hadler; James T Rudrik; Cheleste M Thorpe
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

3.  Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium.

Authors:  G Buvens; S Lauwers; D Piérard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-03       Impact factor: 3.267

4.  Distribution of Novel Og Types in Shiga Toxin-Producing Escherichia coli Isolated from Healthy Cattle.

Authors:  Thi Thu Huong Nguyen; Atsushi Iguchi; Ritsuko Ohata; Hisahiro Kawai; Tadasuke Ooka; Hiroshi Nakajima; Sunao Iyoda
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

5.  Subtilase cytotoxin-coding genes in verotoxin-producing Escherichia coli strains from sheep and goats differ from those from cattle.

Authors:  José A Orden; Pilar Horcajo; Ricardo de la Fuente; José A Ruiz-Santa-Quiteria; Gustavo Domínguez-Bernal; Javier Carrión
Journal:  Appl Environ Microbiol       Date:  2011-09-30       Impact factor: 4.792

6.  Subtilase cytotoxin-encoding subAB operon found exclusively among Shiga toxin-producing Escherichia coli strains.

Authors:  Kinue Irino; Mônica A Midolli Vieira; Tânia A Tardelli Gomes; Beatriz E Cabilio Guth; Zita V Furtado Naves; Murilo Gomes Oliveira; Luis Fernando dos Santos; Mirian Guirro; Claudio D Timm; Caroline P Pigatto; Sonia M S S Farah; Tânia M I Vaz
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

7.  Escherichia coli Subtilase Cytotoxin.

Authors:  Adrienne W Paton; James C Paton
Journal:  Toxins (Basel)       Date:  2010-02-01       Impact factor: 4.546

8.  Factors associated with whole carcass condemnation rates in provincially-inspected abattoirs in Ontario 2001-2007: implications for food animal syndromic surveillance.

Authors:  Gillian D Alton; David L Pearl; Ken G Bateman; W Bruce McNab; Olaf Berke
Journal:  BMC Vet Res       Date:  2010-08-12       Impact factor: 2.741

9.  Suitability of bovine portion condemnations at provincially-inspected abattoirs in Ontario Canada for food animal syndromic surveillance.

Authors:  Gillian D Alton; David L Pearl; Ken G Bateman; W Bruce McNab; Olaf Berke
Journal:  BMC Vet Res       Date:  2012-06-22       Impact factor: 2.741

Review 10.  Prevalence, biogenesis, and functionality of the serine protease autotransporter EspP.

Authors:  André Weiss; Jens Brockmeyer
Journal:  Toxins (Basel)       Date:  2012-12-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.